HALOZYME THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Financial Statements › Balance Sheet › Liabilities › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-02-17
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5.92M.
- 2024-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6.72M.
- 2023-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8.51M.
- 2022-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $12.23M.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $5.92M 10-K · filed 2026-02-17 |
| 2024-12-31 | $6.72M 10-K · filed 2025-02-18 |
| 2023-12-31 | $8.51M 10-K · filed 2024-02-20 |
| 2022-12-31 | $12.23M 10-K · filed 2023-02-21 |
| 2021-12-31 | $124.00K 10-K · filed 2022-02-22 |
| 2021-09-30 | $184.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $253.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $324.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $409.00K 10-K · filed 2021-02-23 |
| 2020-09-30 | $507.00K 10-Q · filed 2020-11-02 |
| 2020-06-30 | $680.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $819.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $775.00K 10-K · filed 2020-02-24 |
| 2019-09-30 | $1.41M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.50M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.72M 10-Q · filed 2019-05-07 |